Role of SAP97 protein in the regulation of corticotropin-releasing factor receptor 1 endocytosis and extracellular signal-regulated kinase 1/2 signaling

Journal of Biological Chemistry

Volumn 288, Issue 21, 2013, Pages 15023-15034

  Dunn, Henry A ^a,b   Walther, Cornelia ^a,b   Godin, Christina M ^a,b   Hall, Randy A ^c   Ferguson, Stephen S G ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CO-IMMUNOPRECIPITATIONS; CORTICOTROPIN-RELEASING FACTORS; DOMAIN-CONTAINING PROTEINS; ENDOCYTIC VESICLES; EXTRACELLULAR- SIGNAL-REGULATED KINASE 1/2; G PROTEIN COUPLED RECEPTORS; PSYCHIATRIC DISEASE; SIGNALING PATHWAYS;

BRAIN; CELL MEMBRANES; CYTOLOGY; DISEASES; MOLECULAR BIOLOGY;

PROTEINS;

CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SHORT HAIRPIN RNA; SYNAPSE ASSOCIATED PROTEIN 97; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; ENDOCYTOSIS; ENDOSOME; ENZYME PHOSPHORYLATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; INTERNALIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PDZ DOMAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CYCLIC AMP (CAMP); ENDOCYTOSIS; ERK; G PROTEIN-COUPLED RECEPTORS (GPCR); RECEPTOR ENDOCYTOSIS; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID MOTIFS; ANIMALS; CELL MEMBRANE; ENDOCYTOSIS; ENDOSOMES; GUANYLATE KINASE; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN TRANSPORT; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 84878231783     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.473660     Document Type: Article

References (52)

1. Vale, W., Spiess, J., Rivier, C., and Rivier, J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213, 1394-1397 (Pubitemid 12243637)
2. Leonard, B. E. (2005) The HPA and immune axes in stress: the involvement of the serotonergic system. Eur. Psychiatry 20, S302-S306
3. Chalmers, D. T., Lovenberg, T. W., Grigoriadis, D. E., Behan, D. P., and De Souza, E. B. (1996) Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17, 166-172 (Pubitemid 26122417)
4. Dautzenberg, F. M., and Hauger, R. L. (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci. 23, 71-77 (Pubitemid 34119328)
5. Chalmers, D. T., Lovenberg, T. W., and De Souza, E. B. (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15, 6340-6350
6. Palchaudhuri, M. R., Wille, S., Mevenkamp, G., Spiess, J., Fuchs, E., and Dautzenberg, F. M. (1998) Corticotropin-releasing factor receptor type 1 from Tupaia belangeri - cloning, functional expression, and tissue distribution. Eur. J. Biochem. 258, 78-84 (Pubitemid 28538310)
7. Overstreet, D. H., and Griebel, G. (2004) Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression. Eur. J. Pharmacol. 497, 49-53 (Pubitemid 39092427)
8. Chaki, S., Nakazato, A., Kennis, L., Nakamura, M., Mackie, C., Sugiura, M., Vinken, P., Ashton, D., Langlois, X., and Steckler, T. (2004) Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur. J. Pharmacol. 485, 145-158 (Pubitemid 38134409)
9. Marshall, F. H. (2001) Heterodimerization of G-protein-coupled receptors in the CNS. Curr. Opin. Pharmacol. 1, 40-44
10. Ferguson, S. S., Zhang, J., Barak, L. S., and Caron, M. G. (1998) Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci. 62, 1561-1565 (Pubitemid 28210241)
11. von Zastrow, M. (2001) Role of endocytosis in signalling and regulation of G-protein-coupled receptors. Biochem. Soc. Trans. 29, 500-504
12. Brady, A. E., and Limbird, L. E. (2002) G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell. Signal. 14, 297-309 (Pubitemid 34164685)
13. Grammatopoulos, D. K., Randeva, H. S., Levine, M. A., Kanellopoulou, K. A., and Hillhouse, E. W. (2001) Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J. Neurochem. 76, 509-519 (Pubitemid 32097028)
14. Gutknecht, E., Van der Linden, I., Van Kolen, K., Verhoeven, K. F., Vauquelin, G., and Dautzenberg, F. M. (2009) Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling. Mol. Pharmacol. 75, 648-657
15. Chen, F. M., Bilezikjian, L. M., Perrin, M. H., Rivier, J., and Vale, W. (1986) Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain. Brain Res. 381, 49-57 (Pubitemid 16049656)
16. Dautzenberg, F. M., Higelin, J., and Teichert, U. (2000) Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells. Eur. J. Pharmacol. 390, 51-59 (Pubitemid 30122436)
17. Grammatopoulos, D. K., and Chrousos, G. P. (2002) Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol. Metab. 13, 436-444 (Pubitemid 36733938)
18. Hauger, R. L., Risbrough, V., Brauns, O., and Dautzenberg, F. M. (2006) Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol. Disord. Drug Targets 5, 453-479 (Pubitemid 44203356)
19. Arzt, E., and Holsboer, F. (2006) CRF signaling: molecular specificity for drug targeting in the CNS. Trends Pharmacol. Sci. 27, 531-538 (Pubitemid 44374761)
20. Holmes, K. D., Babwah, A. V., Dale, L. B., Poulter, M. O., and Ferguson, S. S. (2006) Differential regulation of corticotropin releasing factor 1α receptor endocytosis and trafficking by β-arrestins and Rab GTPases. J. Neurochem. 96, 934-949
21. Oakley, R. H., Olivares-Reyes, J. A., Hudson, C. C., Flores-Vega, F., Dautzenberg, F. M., and Hauger, R. L. (2007) Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and β-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R209-R222 (Pubitemid 47092179)
22. Magalhaes, A. C., Holmes, K. D., Dale, L. B., Comps-Agrar, L., Lee, D., Yadav, P. N., Drysdale, L., Poulter, M. O., Roth, B. L., Pin, J. P., Anisman, H., and Ferguson, S. S. (2010) CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat. Neurosci. 13, 622-629
23. Fam, S. R., Paquet, M., Castleberry, A. M., Oller, H., Lee, C. J., Traynelis, S. F., Smith, Y., Yun, C. C., and Hall, R. A. (2005) P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2. Proc. Natl. Acad. Sci. U.S.A. 102, 8042-8047 (Pubitemid 40781059)
24. He, J., Bellini, M., Inuzuka, H., Xu, J., Xiong, Y., Yang, X., Castleberry, A. M., and Hall, R. A. (2006) Proteomic analysis of β1-adrenergic receptor interactions with PDZ scaffold proteins. J. Biol. Chem. 281, 2820-2827 (Pubitemid 43845746)
25. Cai, C., Li, H., Kangasniemi, A., Pihlajamaa, T., Von Ossowski, L., Kerkelä, K., Schulz, S., Rivera, C., and Keinänen, K. (2008) Somatostatin receptor subtype 1 is a PDZ ligand for synapse-associated protein 97 and a potential regulator of growth cone dynamics. Neuroscience 157, 833-843
26. Bécamel, C., Gavarini, S., Chanrion, B., Alonso, G., Galéotti, N., Dumuis, A., Bockaert, J., and Marin, P. (2004) The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins. J. Biol. Chem. 279, 20257-20266 (Pubitemid 38623471)
27. 1-adrenergic receptor generates a receptosome involved in receptor recycling and networking. J. Biol. Chem. 282, 5085-5099
28. Barak, L. S., Salahpour, A., Zhang, X., Masri, B., Sotnikova, T. D., Ramsey, A. J., Violin, J. D., Lefkowitz, R. J., Caron, M. G., and Gainetdinov, R. R. (2008) Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol. Pharmacol. 74, 585-594
29. Ferguson, S. S., and Caron, M. G. (2004) Green fluorescent protein-tagged β-arrestin translocation as a measure of G protein-coupled receptor activation. Methods Mol. Biol. 237, 121-126
30. Lorenzen, A., Samosh, J., Vandewark, K., Anborgh, P. H., Seah, C., Magalhaes, A. C., Cregan, S. P., Ferguson S. S., and Pasternak S. H. (2010) Rapid and direct transport of cell surface APP to the lysosome defines a novel selective pathway. Mol. Brain. 3, 11
31. Ritter, S. L., and Hall, R. A. (2009) Fine-tuning of GPCR activity by receptor-interacting proteins. Nat. Rev. Mol. Cell Biol. 10, 819-830
32. Magalhaes, A. C., Dunn, H., and Ferguson, S. S. (2012) Regulation ofGPCR activity, trafficking and localization by GPCR-interacting proteins. Br. J. Pharmacol. 165, 1717-1736
33. Kageyama, K., Hanada, K., Moriyama, T., Imaizumi, T., Satoh, K., and Suda, T. (2007) Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells. Mol. Cell. Endocrinol. 263, 90-102 (Pubitemid 44828233)
34. Westendorf, J. M., and Schonbrunn, A. (1985) Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor. Endocrinology 116, 2528-2535 (Pubitemid 15065868)
35. Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., Crompton, A., Chan, A. C., Anderson, J. M., and Cantley, L. C. (1997) Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 275, 73-77 (Pubitemid 27020310)
36. Beuming, T., Skrabanek, L., Niv, M. Y., Mukherjee, P., and Weinstein, H. (2005) PDZBase: a protein-protein interaction database for PDZ-domains. Bioinformatics 21, 827-828 (Pubitemid 40439423)
37. Gardner, L. A., Delos Santos, N. M., Matta, S. G., Whitt, M. A., and Bahouth, S. W. (2004) Role of the cyclic AMP-dependent protein kinase in homologous resensitization of the β1-adrenergic receptor. J. Biol. Chem. 279, 21135-21143 (Pubitemid 38656516)
38. Xia, Z., Gray, J. A., Compton-Toth, B. A., and Roth, B. L. (2003) A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction. J. Biol. Chem. 278, 21901-21908 (Pubitemid 36792597)
39. Gavarini, S., Bécamel, C., Altier, C., Lory, P., Poncet, J., Wijnholds, J., Bockaert, J., and Marin, P. (2006) Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability. Mol. Biol. Cell 17, 4619-4631 (Pubitemid 44665733)
40. Xu, J., Paquet, M., Lau, A. G., Wood, J. D., Ross, C. A., and Hall, R. A. (2001) β1-Adrenergic receptor association with the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 (MAGI-2). Differential regulation of receptor internalization by MAGI-2 and PSD-95. J. Biol. Chem. 276, 41310-41317
41. Gee, H. Y., Kim, Y. W., Jo, M. J., Namkung, W., Kim, J. Y., Park, H. W., Kim, K. S., Kim, H., Baba, A., Yang, J., Kim, E., Kim, K. H., and Lee, M. G. (2009) Synaptic scaffolding molecule binds to and regulates vasoactive intestinal polypeptide type-1 receptor in epithelial cells. Gastroenterology 137, 607-617
42. B receptor association with the PDZ scaffold Mupp1 alters receptor stability and function. J. Biol. Chem. 282, 4162-4171
43. Guillaume, J. L., Daulat, A. M., Maurice, P., Levoye, A., Migaud, M., Brydon, L., Malpaux, B., Borg-Capra, C., and Jockers, R. (2008) The PDZ protein Mupp1 promotes Gi coupling and signaling of the Mt1 melatonin receptor. J. Biol. Chem. 283, 16762-16771
44. Rasmussen, T. N., Novak, I., and Nielsen, S. M. (2004) Internalization of the human CRF receptor 1 is independent of classical phosphorylation sites and of β-arrestin 1 recruitment. Eur. J. Biochem. 271, 4366-4374 (Pubitemid 39576554)
45. Perry, S. J., Junger, S., Kohout, T. A., Hoare, S. R., Struthers, R. S., Grigoriadis, D. E., and Maki, R. A. (2005) Distinct conformations of the corticotropin releasing factor type 1 receptor adopted following agonist and antagonist binding are differentially regulated. J. Biol. Chem. 280, 11560-11568 (Pubitemid 40418468)
46. Wang, B., Yang, Y., Abou-Samra, A. B., and Friedman, P. A. (2009) NH-ERF1 regulates parathyroid hormone receptor desensitization: interference with β-arrestin binding. Mol. Pharmacol. 75, 1189-1197
47. Hu, L. A., Tang, Y., Miller, W. E., Cong, M., Lau, A. G., Lefkowitz, R. J., and Hall, R. A. (2000) β1-Adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of β1-adrenergic receptor interaction with N-methyl-D-aspartate receptors. J. Biol. Chem. 275, 38659-38666 (Pubitemid 32009197)
48. Sabio, G., Arthur, J. S., Kuma, Y., Peggie, M., Carr, J., Murray-Tait, V., Centeno, F., Goedert, M., Morrice, N. A., and Cuenda, A. (2005) p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J. 24, 1134-1145 (Pubitemid 40516597)
49. Sabio, G., Reuver, S., Feijoo, C., Hasegawa, M., Thomas, G. M., Centeno, F., Kuhlendahl, S., Leal-Ortiz, S., Goedert, M., Garner, C., and Cuenda, A. (2004) Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90/PSD-95 by activation of SAPK3/p38γ and ERK1/ERK2. Biochem. J. 380, 19-30 (Pubitemid 38725725)
50. Luttrell, L. M., and Gesty-Palmer, D. (2010) Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol. Rev. 62, 305-330
51. Galandrin, S., Oligny-Longpré, G., and Bouvier, M. (2007) The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol. Sci. 28, 423-430 (Pubitemid 47087968)
52. Kenakin, T. (2007) Functional selectivity through protean and biased agonism: who steers the ship? Mol. Pharmacol. 72, 1393-1401